Stay updated on Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.

Latest updates to the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new publication citation (Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 743) was added to the Publications section. The page revision was updated to v3.5.0, and the Italy location listing was changed from Napoli to Naples (Naples 80131) to reflect naming in English.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. No observable changes to the study details page or its content.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.1 added; Revision: v3.4.0 removed.SummaryDifference0.0%

- Check67 days agoChange DetectedThe update adds UI/metadata changes: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; this is a minor metadata change and does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.